TRI Community EVENT - saturday, 17 May from 8:55am
Australia’s most innovative biomedical research facility, TRI, is showcasing its magnificent building and ground-breaking research to the community on Saturday 17 May.
Take a guided building and science tour and hear from some of Australia’s leading medical researchers, including Dr Fiona Simpson, about innovations in the treatment of cancer, diabetes, inflammatory diseases, HIV, malaria, bone and joint diseases and obesity. Tours are free, suitable for persons aged 12 and over and will run for approximately 40 minutes. Tour spaces are limited and bookings essential.
Tours will run at 8:55am, 9:20am, 9:45am, 10:10am, 10:35am, 10:50am, 11:20am and 11:35am.
Learn how TRI Architects in Association, Wilson Architects + Donovan Hill designed and built this magnificent institute. These talks will be given in the auditorium at 9:45am, 10:30am and 11:15am and run for approximately 30 minutes. Bookings are recommended.
Our onsite café, Catalyst, will open with undercover seating in the green leafy Atrium.
Go to our registration page to book your place and see the full program. Bookings close 5:00pm, Thursday 15 May 2014, unless booked out earlier.
For directions to TRI, see our visitor directions cheat sheet.
Designed by BVN Donovan Hill + Wilson Architects, TRI is a 32,000 square metre building making it the largest medical research institute in the southern hemisphere.
TRI integrates the collective expertise of the University of Queensland’s Diamantina Institute (UQDI) and School of Medicine, Queensland University of Technology’s Institute of Health and Biomedical Innovation (IHBI), Mater Research and the Princess Alexandra Hospital’s Centres for Health Research, together with DSM Biologics.
The Institute has a focus on discovering new therapies and vaccines to prevent and treat common and serious illnesses and diseases that affect the community-at-large. These include breast, prostate, blood, head and neck and skin cancers; diabetes and obesity; infectious diseases such as HIV and malaria, and bone and joint diseases such as rheumatoid arthritis.
Professor Ian Frazer, Australian of the Year 2006 and co-inventor of the cervical cancer vaccine (HPV), is the Chief Executive Officer and Director of Research of the TRI. He describes TRI as a visionary facility whose ‘bench-to-bedside’ research model provides researchers with world-class laboratories, a manufacturer to develop their new drugs for clinical trial, as well as access to the patients for those trials.
“To have a facility that enables new biopharmaceuticals and treatments to be discovered, manufactured and clinically tested in the one location elevates Brisbane’s research capacity and profile internationally as only a few places in the world have such capability.
“TRI will facilitate collaborations between those involved in the development of new drugs and therapies and better enable researchers from its four partners to work together with common purpose, for a common good.”
Hear from some of TRI's innovative researchers including CEO and Director of Research Professor Ian Frazer, talk about their work and what it means to work at TRI. Learn how TRI came about, some of the research focuses and how TRI aims to contribute to solving some major illnesses and diseases among the community.
At our community morning, chief TRI architects from BVN Donovan Hill + Wilson Architects will talk about the process they followed to design and build our magnificent institute; talks will be at 9:45am, 10:30am and 11:15am and run for approximately 30 minutes. Bookings are recommended
What's been happening at TRI lately
A breakthrough by TRI based, Mater researcher Associate Professor Ingrid Winkler could relieve suffering for patients during cancer treatment. Watch Prof Winkler discuss the future application of her research
